Mosaic ImmunoEngineering, Inc.
CPMV
$0.98
$0.27839.60%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -23.48% | -21.73% | -39.44% | -38.93% | -40.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -38.03% | -38.12% | -48.74% | -46.73% | -45.11% |
| Operating Income | 38.03% | 38.12% | 48.74% | 46.73% | 45.11% |
| Income Before Tax | 14.45% | -13.73% | 55.37% | 57.71% | 53.82% |
| Income Tax Expenses | -100.00% | -100.00% | -100.00% | 0.00% | 0.00% |
| Earnings from Continuing Operations | 14.61% | -13.47% | 55.48% | 57.65% | 53.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.61% | -13.47% | 55.48% | 57.65% | 53.78% |
| EBIT | 38.03% | 38.12% | 48.74% | 46.73% | 45.11% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 14.63% | -13.57% | 55.46% | 57.66% | 53.78% |
| Normalized Basic EPS | 35.47% | 32.84% | 47.30% | 46.10% | 44.43% |
| EPS Diluted | 14.41% | -15.59% | 54.07% | 56.47% | 53.07% |
| Normalized Diluted EPS | 33.36% | 30.83% | 49.51% | 48.07% | 46.19% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.01% | 0.01% | 0.03% |
| Average Diluted Shares Outstanding | -4.40% | -4.40% | 4.61% | 4.62% | 4.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
